[COVID-19 Vaccines for Patients with Neuroimmunological Diseases].
Brain Nerve
; 74(7): 899-904, 2022 Jul.
Article
in Japanese
| MEDLINE | ID: covidwho-1954945
ABSTRACT
More than 2 years have passed since the outbreak of coronavirus disease 2019 (COVID-19), but there is still no sign that the COVID-19 pandemic has ended. Although vaccines have shown high efficacy against severe acute respiratory syndrome coronavirus 2, a risk of adverse reactions and thrombosis has also been reported. Here we review the current knowledge regarding vaccination in patients with neuroimmunological diseases and those receiving immunosuppressive drugs or disease-modifying therapy.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pandemics
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
Japanese
Journal:
Brain Nerve
Journal subject:
Brain
/
Neurology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS